Litcius/Paper detail

Efficacy and safety of dapagliflozin compared to pioglitazone in diabetic and non-diabetic patients with non-alcoholic steatohepatitis: A randomized clinical trial

Mona S. Abdel Monem, Abdulmoneim Adel, Maggie Abbassi, Doaa H. Abdelaziz, Mohamed Hassany, Maissa El Raziky, Nirmeen A. Sabry

2025Clinics and Research in Hepatology and Gastroenterology12 citationsDOI

Topics & Concepts

MedicinePioglitazoneDapagliflozinSteatohepatitisDiabetes mellitusRandomized controlled trialInternal medicineGastroenterologyFatty liverType 2 diabetesEndocrinologyDiseaseLiver Disease Diagnosis and TreatmentDiabetes, Cardiovascular Risks, and LipoproteinsPancreatitis Pathology and Treatment
Efficacy and safety of dapagliflozin compared to pioglitazone in diabetic and non-diabetic patients with non-alcoholic steatohepatitis: A randomized clinical trial | Litcius